These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


910 related items for PubMed ID: 1564678

  • 21. A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels.
    Saleh WA, Burkman RT, Zacur HA, Kimball AW, Kwiterovich P, Bell WK.
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1740-5; discussion 1745-7. PubMed ID: 8317516
    [Abstract] [Full Text] [Related]

  • 22. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
    Russowsky M, Sartoretto JN.
    Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS, Ayerst RI, Harris JW, Stone RA, Anderson AE, Jones TL, Curtis MK.
    Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
    [Abstract] [Full Text] [Related]

  • 24. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
    Lussier-Cacan S, Xhignesse M, Desmarais JL, Davignon J, Kafrissen ME, Chapdelaine A.
    Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
    [Abstract] [Full Text] [Related]

  • 25. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 26. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial.
    Dunson TR, McLaurin VL, Israngkura B, Leelapattana B, Mukherjee R, Perez-Palacios G, Saleh AA.
    Contraception; 1993 Aug; 48(2):109-19. PubMed ID: 8403908
    [Abstract] [Full Text] [Related]

  • 27. Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
    van der Does J, Exalto N, Dieben T, Bennink HC.
    Contraception; 1995 Dec; 52(6):357-61. PubMed ID: 8749599
    [Abstract] [Full Text] [Related]

  • 28. Three triphasic oral contraceptives now available in U.S.
    Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
    [Abstract] [Full Text] [Related]

  • 29. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES, Cruickshank J, McMaster M, Weir RJ.
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH, Bolding OT, Chenault CB, Chong AP, Fleury F, Forrest K, Glick HI, Hasson HM, Heil CG, London RS.
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
    Freeman EW, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, Zhang P, Patel H, Foegh M, PMS/PMDD Research Group.
    J Womens Health Gend Based Med; 2001 May; 10(6):561-9. PubMed ID: 11559453
    [Abstract] [Full Text] [Related]

  • 32. Long-term experience with a low-dose oral contraceptive.
    Brill K, Schnitker J, Albring M.
    Gynecol Endocrinol; 1990 Dec; 4(4):277-86. PubMed ID: 2150581
    [Abstract] [Full Text] [Related]

  • 33. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A.
    Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
    [Abstract] [Full Text] [Related]

  • 34. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
    Spona J, Elstein M, Feichtinger W, Sullivan H, Lüdicke F, Müller U, Düsterberg B.
    Contraception; 1996 Aug; 54(2):71-7. PubMed ID: 8842582
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
    Weisberg E, Fraser IS, Lacarra M, Mishell DR, Alvarez F, Brache V, Nash HA.
    Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
    [Abstract] [Full Text] [Related]

  • 37. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use.
    Graham CA, Sherwin BB.
    J Psychosom Res; 1987 May; 31(1):45-53. PubMed ID: 3820145
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T, Lindheim SR, Duffy DM, Vijod MA, Stanczyk FZ, Lobo RA.
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 46.